Internal Medicine, Infectious Disease · Concord, NC
NPI
1710114046
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Medical Park Dr, Ste 280
Concord, NC, 28025
Phone (704) 403-1766
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
756 services
Medicare patients, 2024
219
Average age 72
Drug cost, 2024
$590K
587 prescriptions
Company payments, 2024
$13.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Zulfiqar was code 99232 (hospital e&m - subsequent), 405 times for 150 patients. In total Sara Zulfiqar billed 756 services in 11 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 405 | 150 | $56.98 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 131 | 89 | $85.50 | $11K |
| 99222 Hospital E&M - Initial | Facility | 123 | 115 | $91.92 | $11K |
| 99214 Office E&M - Established | Office | 34 | 25 | $84.35 | $2,868 |
| 99223 Hospital E&M - Initial | Facility | 34 | 33 | $121.55 | $4,133 |
By year: 2022 $65K for 806 services; 2023 $53K for 677 services; 2024 $55K for 756 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara Zulfiqar prescribed most often to Medicare patients was Cephalexin, with 60 prescriptions and refills. In total Sara Zulfiqar wrote 587 Medicare prescriptions that cost $590K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 60 | 92 | 14 | $1,626 |
| Daptomycin Generic | 54 | 54 | 14 | $67K |
| Ceftriaxone Ceftriaxone Sodium | 51 | 51 | 12 | $3,070 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 42 | 70 | 19 | $1,405 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 38 | 38 | Under 11 | $153K |
| Cefazolin Sodium Generic | 37 | 37 | Under 11 | $2,444 |
| Vancomycin Hcl Generic | 27 | 27 | Under 11 | $4,411 |
| Doxycycline Hyclate Generic | 25 | 49 | Under 11 | $2,202 |
| Levofloxacin Generic | 24 | 39 | Under 11 | $246 |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 23 | 23 | Under 11 | $110K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 19 | 19 | Under 11 | $75K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 16 | 16 | Under 11 | $3,050 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 36 | Under 11 | $211 |
| Cefepime Hcl Generic | 15 | 15 | Under 11 | $6,700 |
| Ertapenem Ertapenem Sodium | 13 | 13 | Under 11 | $4,477 |
Brand drugs: 135 claims; generic drugs: 452 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sara Zulfiqar $13.18 ($13.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $13.18.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $13.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.